SLOT: Full Definition
What is anastrozole?
Anastrozole — sold under the brand name Arimidex — is an oral medication in the aromatase inhibitor class. It works by blocking the enzyme aromatase, which converts androgens (like testosterone) into estrogen in fat, muscle, breast, and other tissues. By inhibiting aromatase, anastrozole lowers circulating estrogen levels — a useful effect in some clinical situations and a problem in others.
Anastrozole is FDA-approved primarily for postmenopausal women with hormone-receptor-positive breast cancer, both as adjuvant treatment after surgery and for metastatic disease. It is also used off-label in fertility medicine, in men with elevated estrogen on testosterone therapy, and occasionally as an adjunct in Bioidentical Hormone Replacement Therapy when estrogen levels rise above target on testosterone replacement. Anastrozole is not part of the standard care plan at Modern Thyroid Clinic, but our patients sometimes encounter it through oncology or specialty hormone clinics, and we coordinate the broader thyroid and metabolic care.
How does anastrozole work?
In postmenopausal women, the ovaries are no longer the main estrogen source. Most circulating estrogen comes from peripheral conversion of adrenal androgens by the aromatase enzyme. Anastrozole inhibits this conversion, lowering serum estradiol substantially — by 80% or more in many women. For estrogen-receptor-positive breast cancer, this estrogen suppression slows or halts tumor growth.
In other off-label contexts, anastrozole is sometimes used to fine-tune the testosterone-to-estradiol ratio — for example, in male testosterone replacement protocols, or rarely in female pellet-based hormone therapy where excess aromatization has driven estradiol too high.
When is anastrozole prescribed?
Common indications include:
- Adjuvant treatment of hormone-receptor-positive breast cancer in postmenopausal women
- Metastatic breast cancer with hormone-sensitive disease
- Off-label fertility uses — sometimes in ovulation induction protocols, particularly for women with low ovarian reserve
- Off-label adjunct in some hormone replacement protocols where Estradiol climbs too high (an uncommon scenario in well-titrated bioidentical therapy)
Patient considerations
Because anastrozole dramatically lowers estrogen, most side effects reflect estrogen deficiency:
- Joint stiffness and aches (the most common reason women stop the medication)
- Hot flashes and night sweats
- Vaginal dryness, painful sex, urinary symptoms
- Bone loss — accelerated osteopenia/osteoporosis is a real concern over time
- Mood changes, sleep disturbance, brain fog
- Hair thinning, skin changes
Women on anastrozole should have bone density monitoring, vitamin D and calcium adequacy, strength training, and supportive care for vasomotor and genitourinary symptoms. Vaginal estrogen at low doses can usually be used safely under oncologic supervision.
Anastrozole is a powerful tool with real trade-offs. In breast cancer it can be life-saving and the side effects are accepted as part of the treatment. Off-label uses for hormone replacement deserve more skepticism — at MTC we believe well-titrated bioidentical therapy rarely needs an aromatase inhibitor, and we are cautious about any protocol that routinely adds one. Decisions about anastrozole should always be made with the specialist directing your care.
Common symptoms
Common questions
Why is anastrozole sometimes used with hormone replacement?
Most often in pellet-based testosterone protocols where supraphysiologic testosterone is administered and aromatizes — converting to estradiol — pushing estrogen levels above target. Some clinicians add anastrozole to bring estradiol back down. At Modern Thyroid Clinic we view this as a sign that the underlying testosterone dosing is too high or the route is not ideal, rather than a problem to be solved with a second medication. Properly dosed, individualized [bioidentical-hormone-replacement-therapy] with [estradiol] and [testosterone-therapy-women] rarely requires an aromatase inhibitor. Always discuss the plan with your prescribing clinician.
Will anastrozole cause bone loss?
Yes — it is one of the most consistent and important side effects of aromatase inhibitors. By substantially lowering estrogen, anastrozole accelerates bone resorption. Women on anastrozole, particularly for breast cancer, should have a baseline DEXA scan and serial monitoring, ensure adequate vitamin D and calcium, prioritize resistance training and weight-bearing exercise, and address sleep and protein intake. In some cases, bone-protective medications (such as bisphosphonates or denosumab) are added. The bone effect is one reason aromatase inhibitors are generally not appropriate as casual adjuncts to standard hormone replacement.
Can I use vaginal estrogen if I am on anastrozole?
For many women, yes — under oncologic supervision. Low-dose vaginal estradiol or vaginal DHEA primarily acts locally with minimal systemic absorption, and quality-of-life improvements (relief from painful sex, dryness, recurrent UTIs) are substantial. The decision involves weighing local benefit against any small theoretical risk of systemic estrogen elevation, which has been reassuring in available data. Most oncology guidelines now consider low-dose vaginal estrogen acceptable for breast cancer survivors who have severe genitourinary symptoms not adequately managed by non-hormonal options. Always coordinate with your oncology team.
Think you might be dealing with this?
Talk to a Modern Thyroid Clinic specialist about your symptoms, labs, and next steps.
Book a Discovery CallThis content is for educational purposes only and is not medical advice. Consult a licensed clinician for diagnosis and treatment. Content on this page does not create a doctor-patient relationship with Modern Thyroid Clinic.